{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T10:56:35Z","timestamp":1793876195505,"version":"4.7.0"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013058","name":"Jiangsu Provincial Key Research and Development Program","doi-asserted-by":"publisher","award":["BE2021736"],"award-info":[{"award-number":["BE2021736"]}],"id":[{"id":"10.13039\/501100013058","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.diabres.2023.111079","type":"journal-article","created":{"date-parts":[[2023,12,26]],"date-time":"2023-12-26T16:10:29Z","timestamp":1703607029000},"page":"111079","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Risk factors for peripheral artery disease and diabetic peripheral neuropathy among patients with type 2 diabetes"],"prefix":"10.1016","volume":"207","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2273-9108","authenticated-orcid":false,"given":"Tian","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjue","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengdong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingquan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naifeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2023.111079_b0005","doi-asserted-by":"crossref","first-page":"107954","DOI":"10.1016\/j.diabres.2019.107954","article-title":"IDF Congress 2019: Shaping the future of diabetes.","volume":"158","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"10.1016\/j.diabres.2023.111079_b0010","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF00281114","article-title":"Type 2 (non-insulin-dependent) diabetes mellitus and coronary heart disease-chicken, egg or neither?","volume":"26","author":"Jarrett","year":"1984","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.diabres.2023.111079_b0015","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2337\/diab.44.4.369","article-title":"Diabetes and cardiovascular disease. The \u201ccommon soil\u201d hypothesis","volume":"44","author":"Stern","year":"1995","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.diabres.2023.111079_b0020","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1177\/1479164109336043","article-title":"Prevalence and risk factors for peripheral artery disease in an Asian population with diabetes mellitus","volume":"6","author":"Tavintharan","year":"2009","journal-title":"Diab Vasc Dis Res"},{"issue":"9","key":"10.1016\/j.diabres.2023.111079_b0025","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1161\/CIRCRESAHA.116.303849","article-title":"Epidemiology of peripheral artery disease","volume":"116","author":"Criqui","year":"2015","journal-title":"Circ Res"},{"issue":"12","key":"10.1016\/j.diabres.2023.111079_b0030","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1046\/j.1464-5491.2003.01046.x","article-title":"Peripheral vascular disease in Type 2 diabetic Chinese patients: Associations with metabolic indices, concomitant vascular disease and genetic factors","volume":"20","author":"Thomas","year":"2003","journal-title":"Diabet Med"},{"issue":"3","key":"10.1016\/j.diabres.2023.111079_b0035","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/000331970305400309","article-title":"Prevalence and risk factors of peripheral arterial obstructive disease in Taiwanese type 2 diabetic patients","volume":"54","author":"Tseng","year":"2003","journal-title":"Angiology"},{"key":"10.1016\/j.diabres.2023.111079_b0040","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.atherosclerosis.2018.05.033","article-title":"Update on peripheral artery disease: Epidemiology and evidence-based facts","volume":"275","author":"Shu","year":"2018","journal-title":"Atherosclerosis"},{"issue":"8","key":"10.1016\/j.diabres.2023.111079_b0045","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s11883-018-0742-x","article-title":"Peripheral arterial disease in women: An overview of risk factor profile, clinical features, and outcomes","volume":"20","author":"Jelani","year":"2018","journal-title":"Curr Atheroscler Rep"},{"issue":"2_suppl","key":"10.1016\/j.diabres.2023.111079_b0050","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/2047487319880044","article-title":"Lower extremity artery disease in patients with type 2 diabetes","volume":"26","author":"Buso","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.diabres.2023.111079_b0055","series-title":"A progress report of the International Working Group on the Diabetic Foot. Diabetes Metab Res Rev 28 Suppl 1:218\u201324","article-title":"Diagnosis and treatment of peripheral arterial disease in diabetic patients with a foot ulcer","author":"Schaper","year":"2012"},{"issue":"8","key":"10.1016\/j.diabres.2023.111079_b0060","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.2337\/diacare.24.8.1433","article-title":"Peripheral arterial disease in diabetic and nondiabetic patients: A comparison of severity and outcome","volume":"24","author":"Jude","year":"2001","journal-title":"Diabetes Care"},{"issue":"9901","key":"10.1016\/j.diabres.2023.111079_b0065","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis","volume":"382","author":"Fowkes","year":"2013","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.diabres.2023.111079_b0070","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.2337\/diacare.26.6.1790","article-title":"The health care costs of diabetic peripheral neuropathy in the US","volume":"26","author":"Gordois","year":"2003","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.diabres.2023.111079_b0075","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/iwj.13540","article-title":"Clinical and economic burden of diabetic foot ulcers: A 5-year longitudinal multi-ethnic cohort study from the tropics","volume":"18","author":"Lo","year":"2021","journal-title":"Int Wound J"},{"key":"10.1016\/j.diabres.2023.111079_b0080","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.atherosclerosis.2018.04.026","article-title":"Peripheral vascular disease risk in diabetic individuals without coronary heart disease","volume":"275","author":"Wilcox","year":"2018","journal-title":"Atherosclerosis"},{"issue":"7","key":"10.1016\/j.diabres.2023.111079_b0085","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabet Med"},{"issue":"4","key":"10.1016\/j.diabres.2023.111079_b0090","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/hr.2014.20","article-title":"The japanese society of hypertension guidelines for the management of hypertension (JSH 2014)","volume":"37","author":"Shimamoto","year":"2014","journal-title":"Hypertens Res"},{"issue":"2","key":"10.1016\/j.diabres.2023.111079_b0095","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jacl.2015.02.003","article-title":"National lipid association recommendations for patient-centered management of dyslipidemia: Part 1\u2013full report","volume":"9","author":"Jacobson","year":"2015","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.diabres.2023.111079_b0100","unstructured":"Chinese guidelines on prevention and treatment of dyslipidemia in adults Zhonghua Xin Xue Guan Bing Za Zhi 35 (5): 2007 390-419."},{"issue":"2","key":"10.1016\/j.diabres.2023.111079_b0105","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/BF00400697","article-title":"A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population","volume":"36","author":"Young","year":"1993","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2023.111079_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109063","article-title":"Screening, diagnosis and management of diabetic sensorimotor polyneuropathy in clinical practice: International expert consensus recommendations","volume":"186","author":"Ziegler","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"10.1016\/j.diabres.2023.111079_b0115","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1212\/01.WNL.0000149522.32823.EA","article-title":"Distal symmetric polyneuropathy: A definition for clinical research: Report of the american academy of neurology, the american association of electrodiagnostic medicine, and the american academy of physical medicine and rehabilitation","volume":"64","author":"England","year":"2005","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.diabres.2023.111079_b0120","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4093\/dmj.2018.0056","article-title":"Diagnosing diabetic neuropathy: Something old","volume":"42","author":"Petropoulos","year":"2018","journal-title":"Something New Diabetes Metab J"},{"issue":"5","key":"10.1016\/j.diabres.2023.111079_b0125","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1177\/0013164499595001","article-title":"Effectiveness of different missing data treatments in surveys with Likert-type data: Introducing the relative mean substitution approach","volume":"59","author":"Raaijmakers","year":"1995","journal-title":"Educ Psychol Meas"},{"issue":"4","key":"10.1016\/j.diabres.2023.111079_b0130","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3758\/BRM.41.4.1149","article-title":"Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses","volume":"41","author":"Faul","year":"2009","journal-title":"Behav Res Methods"},{"issue":"1","key":"10.1016\/j.diabres.2023.111079_b0135","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1191\/1358863x06vm663oa","article-title":"Limitation of the resting ankle-brachial index in symptomatic patients with peripheral arterial disease","volume":"11","author":"Stein","year":"2006","journal-title":"Vasc Med"},{"issue":"6","key":"10.1016\/j.diabres.2023.111079_b0140","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1161\/01.CIR.0000112642.63927.54","article-title":"Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: The strong heart study","volume":"109","author":"Resnick","year":"2004","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.diabres.2023.111079_b0145","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1464-5491.2008.02397.x","article-title":"Prevalence and risk factors for diabetic neuropathy in an urban south Indian population: The Chennai Urban Rural Epidemiology Study (CURES-55)","volume":"25","author":"Pradeepa","year":"2008","journal-title":"Diabet Med"},{"issue":"2","key":"10.1016\/j.diabres.2023.111079_b0150","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jdiacomp.2012.02.001","article-title":"Prevalence and risk factors for diabetic microvascular complications in newly diagnosed type II diabetes mellitus. Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS, report 27)","volume":"26","author":"Raman","year":"2012","journal-title":"J Diabetes Complications"},{"issue":"3","key":"10.1016\/j.diabres.2023.111079_b0155","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.dsx.2012.09.002","article-title":"Explorative study on diabetes neuropathy among type II diabetic patients in Universiti Sains Malaysia Hospital","volume":"6","author":"Abougalambou","year":"2012","journal-title":"Diabetes Metab Syndr"},{"issue":"7","key":"10.1016\/j.diabres.2023.111079_b0160","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2337\/diacare.27.7.1591","article-title":"Prevalence of lower-extremity disease in the US adult population >=40 years of age with and without diabetes: 1999\u20132000 national health and nutrition examination survey","volume":"27","author":"Gregg","year":"2004","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.diabres.2023.111079_b0165","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/jdi.12223","article-title":"Prevalence and risk factors of development of peripheral diabetic neuropathy in type 2 diabetes mellitus in a tertiary care setting","volume":"5","author":"Bansal","year":"2014","journal-title":"J Diabetes Investig"},{"issue":"6","key":"10.1016\/j.diabres.2023.111079_b0170","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1161\/CIRCULATIONAHA.116.022971","article-title":"Parsing atherosclerosis: The unnatural history of peripheral artery disease","volume":"134","author":"Aronow","year":"2016","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.diabres.2023.111079_b0175","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/j.jacc.2016.11.007","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: A report of the american college of cardiology\/american heart association task force on clinical practice guidelines","volume":"69","author":"Gerhard-Herman","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.diabres.2023.111079_b0180","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1161\/CIR.0000000000001005","article-title":"Lower extremity peripheral artery disease: contemporary epidemiology, management gaps, and future directions: A scientific statement from the american heart association","volume":"144","author":"Criqui","year":"2021","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.diabres.2023.111079_b0185","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1161\/CIRCULATIONAHA.121.053797","article-title":"Prioritizing the role of major lipoproteins and subfractions as risk factors for peripheral artery disease","volume":"144","author":"Levin","year":"2021","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.diabres.2023.111079_b0190","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1161\/CIRCULATIONAHA.118.036347","article-title":"Unraveling the risk of peripheral artery disease","volume":"138","author":"Joshi","year":"2018","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.diabres.2023.111079_b0195","doi-asserted-by":"crossref","first-page":"894","DOI":"10.2337\/diacare.25.5.894","article-title":"UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes","volume":"25","author":"Adler","year":"2002","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.diabres.2023.111079_b0200","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2337\/diacare.29.03.06.dc05-1567","article-title":"Peripheral arterial disease and risk of cardiac death in type 2 diabetes: The fremantle diabetes study","volume":"29","author":"Norman","year":"2006","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.diabres.2023.111079_b0205","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jdiacomp.2014.04.013","article-title":"Prevalence, incidence and progression of peripheral arterial disease in Asian Indian type 2 diabetic patients","volume":"28","author":"Eshcol","year":"2014","journal-title":"J Diabetes Complications"},{"issue":"5","key":"10.1016\/j.diabres.2023.111079_b0210","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.2337\/dc13-2303","article-title":"Risk factors for incident peripheral arterial disease in type 2 diabetes: Results from the bypass angioplasty revascularization investigation in type 2 diabetes (BARI 2D) trial","volume":"37","author":"Althouse","year":"2014","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.diabres.2023.111079_b0215","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.2337\/dc16-0588","article-title":"Microvascular and macrovascular disease and risk for major peripheral arterial disease in patients with type 2 diabetes","volume":"39","author":"Mohammedi","year":"2016","journal-title":"Diabetes Care"},{"issue":"9131","key":"10.1016\/j.diabres.2023.111079_b0220","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","year":"1998","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.diabres.2023.111079_b0225","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2337\/dc08-9026","volume":"32","author":"Skyler","year":"2009","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.diabres.2023.111079_b0230","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with type 2 diabetes","volume":"360","author":"Duckworth","year":"2009","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.diabres.2023.111079_b0235","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Patel","year":"2008","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.diabres.2023.111079_b0240","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.cjca.2022.02.029","article-title":"Canadian cardiovascular society 2022 guidelines for peripheral arterial disease","volume":"38","author":"Abramson","year":"2022","journal-title":"Can J Cardiol"},{"issue":"3","key":"10.1016\/j.diabres.2023.111079_b0245","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s00125-020-05326-x","article-title":"Plasma concentrations of lipoproteins and risk of lower-limb peripheral artery disease in people with type 2 diabetes: The SURDIAGENE study","volume":"64","author":"Bertrand","year":"2021","journal-title":"Diabetologia"},{"issue":"19","key":"10.1016\/j.diabres.2023.111079_b0250","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","year":"2001","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.diabres.2023.111079_b0255","doi-asserted-by":"crossref","first-page":"365","DOI":"10.47102\/annals-acadmedsg.V37N5p365","article-title":"Risk factor profile and treatment patterns of patients with atherothrombosis in Singapore: Insight from the REACH Registry","volume":"37","author":"Yeo","year":"2008","journal-title":"Ann Acad Med Singap"},{"issue":"7","key":"10.1016\/j.diabres.2023.111079_b0260","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1177\/0003319714566228","article-title":"Serum uric acid, gender, and low ankle brachial index in adults with high cardiovascular risk","volume":"66","author":"Zhan","year":"2015","journal-title":"Angiology"},{"issue":"1","key":"10.1016\/j.diabres.2023.111079_b0265","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.amjcard.2012.02.061","article-title":"Risk factors for peripheral arterial disease among patients with chronic kidney disease","volume":"110","author":"Chen","year":"2012","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.diabres.2023.111079_b0270","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.atherosclerosis.2006.12.029","article-title":"Association between serum uric acid level and peripheral arterial disease","volume":"196","author":"Shankar","year":"2008","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.diabres.2023.111079_b0275","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1161\/01.HYP.0000069700.62727.C5","article-title":"Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?","volume":"41","author":"Johnson","year":"2003","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.diabres.2023.111079_b0280","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1023\/A:1024600905574","article-title":"Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers","volume":"18","author":"Nakanishi","year":"2003","journal-title":"Eur J Epidemiol"},{"issue":"11","key":"10.1016\/j.diabres.2023.111079_b0285","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1093\/aje\/kwg260","article-title":"Risk factors for progression to incident hyperinsulinemia: The Atherosclerosis Risk in Communities Study, 1987\u20131998","volume":"158","author":"Carnethon","year":"2003","journal-title":"Am J Epidemiol"},{"issue":"8","key":"10.1016\/j.diabres.2023.111079_b0290","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1161\/01.STR.0000081983.34771.D2","article-title":"Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke","volume":"34","author":"Weir","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.diabres.2023.111079_b0295","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.atherosclerosis.2018.10.007","article-title":"Hyperuricemia and endothelial function: From molecular background to clinical perspectives","volume":"278","author":"Maruhashi","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.diabres.2023.111079_b0300","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ijcard.2018.06.017","article-title":"Cross-sectional and longitudinal associations between serum uric acid and endothelial function in subjects with treated hypertension","volume":"272","author":"Tanaka","year":"2018","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.diabres.2023.111079_b0305","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1161\/HYPERTENSIONAHA.116.08114","article-title":"Longitudinal association between serum uric acid and arterial stiffness: Results from the baltimore longitudinal study of aging","volume":"69","author":"Canepa","year":"2017","journal-title":"Hypertension"},{"issue":"17","key":"10.1016\/j.diabres.2023.111079_b0310","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.2169\/internalmedicine.54.4310","article-title":"The effects of allopurinol on the carotid intima-media thickness in patients with type 2 diabetes and asymptomatic hyperuricemia: A three-year randomized parallel-controlled study","volume":"54","author":"Liu","year":"2015","journal-title":"Intern Med"},{"issue":"4","key":"10.1016\/j.diabres.2023.111079_b0315","doi-asserted-by":"crossref","first-page":"e1003095","DOI":"10.1371\/journal.pmed.1003095","article-title":"Febuxostat does not delay progression of carotid atherosclerosis in patients with asymptomatic hyperuricemia: A randomized, controlled trial","volume":"17","author":"Tanaka","year":"2020","journal-title":"PLoS Med"},{"issue":"4","key":"10.1016\/j.diabres.2023.111079_b0320","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/s41440-022-00857-9","article-title":"Differential effect of a xanthine oxidase inhibitor on arterial stiffness and carotid atherosclerosis: A subanalysis of the PRIZE study","volume":"45","author":"Shiina","year":"2022","journal-title":"Hypertens Res"},{"issue":"1","key":"10.1016\/j.diabres.2023.111079_b0325","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002226","article-title":"Association between serum urate level and carotid atherosclerosis: An insight from a post hoc analysis of the PRIZE randomised clinical trial","volume":"8","author":"Tanaka","year":"2022","journal-title":"RMD Open"},{"issue":"18","key":"10.1016\/j.diabres.2023.111079_b0330","first-page":"1241","article-title":"A multicenter survey on the diabetic foot and its neuropathy in China","volume":"87","author":"Lin","year":"2007","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.diabres.2023.111079_b0335","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2147\/DMSO.S185614","article-title":"Glycemic control and diabetes complications among diabetes mellitus patients attending at university of gondar hospital, Northwest Ethiopia","volume":"12","author":"Fasil","year":"2019","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.diabres.2023.111079_b0340","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2147\/DMSO.S227664","article-title":"Glycemic control, diabetes complications and their determinants among ambulatory diabetes mellitus patients in southwest ethiopia: A prospective cross-sectional study","volume":"13","author":"YimamAhmed","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"9","key":"10.1016\/j.diabres.2023.111079_b0345","doi-asserted-by":"crossref","DOI":"10.1177\/03000605211044366","article-title":"Identification of independent risk factors for diabetic neuropathy progression in patients with type 2 diabetes mellitus","volume":"49","author":"Huang","year":"2021","journal-title":"J Int Med Res"},{"issue":"2","key":"10.1016\/j.diabres.2023.111079_b0350","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212574","article-title":"The risk factors for diabetic peripheral neuropathy: A meta-analysis","volume":"14","author":"Liu","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.diabres.2023.111079_b0355","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1758-5996-4-21","article-title":"The prevalence, patterns and predictors of diabetic peripheral neuropathy in a developing country","volume":"4","author":"Katulanda","year":"2012","journal-title":"Diabetol Metab Syndr"},{"issue":"4","key":"10.1016\/j.diabres.2023.111079_b0360","doi-asserted-by":"crossref","first-page":"476","DOI":"10.2337\/diab.37.4.476","article-title":"Factors in development of diabetic neuropathy. Baseline analysis of neuropathy in feasibility phase of Diabetes Control and Complications Trial (DCCT)","volume":"37","year":"1988","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.diabres.2023.111079_b0365","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.genm.2010.11.001","article-title":"Earlier development of diabetic neuropathy in men than in women with type 2 diabetes mellitus","volume":"7","author":"Kamenov","year":"2010","journal-title":"Gend Med"},{"issue":"2","key":"10.1016\/j.diabres.2023.111079_b0370","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jdiacomp.2007.06.009","article-title":"Gender differences in the onset of diabetic neuropathy","volume":"22","author":"Aaberg","year":"2008","journal-title":"J Diabetes Complications"},{"issue":"9","key":"10.1016\/j.diabres.2023.111079_b0375","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1007\/s00018-007-7002-5","article-title":"Testosterone derivatives are neuroprotective agents in experimental diabetic neuropathy","volume":"64","author":"Roglio","year":"2007","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.diabres.2023.111079_b0380","article-title":"Female sex is a risk factor for painful diabetic peripheral neuropathy: The EURODIAB prospective diabetes complications study","author":"Elliott","year":"2023","journal-title":"Diabetologia"},{"issue":"8","key":"10.1016\/j.diabres.2023.111079_b0385","doi-asserted-by":"crossref","first-page":"629","DOI":"10.7326\/0003-4819-134-8-200104170-00007","article-title":"Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial","volume":"134","author":"Mann","year":"2001","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.diabres.2023.111079_b0390","first-page":"7","article-title":"Vascular calcifications in chronic kidney disease\u2013clinical management","volume":"53","author":"Checheri\u0163\u0103","year":"2012","journal-title":"Rom J Morphol Embryol"},{"issue":"3","key":"10.1016\/j.diabres.2023.111079_b0395","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.numecd.2022.11.013","article-title":"Positive association between urinary albumin-creatinine ratio and lower extremity peripheral arterial disease in Chinese diabetes patients: A cross-section study with propensity score matching analysis","volume":"33","author":"Wang","year":"2023","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"9","key":"10.1016\/j.diabres.2023.111079_b0400","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S2213-8587(17)30183-3","article-title":"Measures of chronic kidney disease and risk of incident peripheral artery disease: A collaborative meta-analysis of individual participant data","volume":"5","author":"Matsushita","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"10.1016\/j.diabres.2023.111079_b0405","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1530\/EJE-14-0381","article-title":"Association between serum cystatin C and diabetic peripheral neuropathy: A cross-sectional study of a Chinese type 2 diabetic population","volume":"171","author":"Hu","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.diabres.2023.111079_b0410","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1053\/ajkd.2002.34487","article-title":"Serum cystatin C is superior to serum creatinine as a marker of kidney function: A meta-analysis","volume":"40","author":"Dharnidharka","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.diabres.2023.111079_b0415","first-page":"14","article-title":"The relationship between plasma homocysteine levels and diabetic peripheral neuropathy","volume":"50","author":"Li","year":"2011","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"30","key":"10.1016\/j.diabres.2023.111079_b0420","first-page":"2384","article-title":"Is the C677T polymorphism in methylenetetrahydrofolate reductase gene or plasma homocysteine a risk factor for diabetic peripheral neuropathy in Chinese individuals?","volume":"7","author":"Wang","year":"2012","journal-title":"Neural Regen Res"},{"issue":"9921","key":"10.1016\/j.diabres.2023.111079_b0425","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0140-6736(13)61752-3","article-title":"The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective","volume":"383","author":"Mahmood","year":"2014","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.diabres.2023.111079_b0430","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1161\/STROKEAHA.107.496752","article-title":"Cigarette smoking, systolic blood pressure, and cardiovascular diseases in the Asia-Pacific region","volume":"39","author":"Nakamura","year":"2008","journal-title":"Stroke"},{"issue":"22","key":"10.1016\/j.diabres.2023.111079_b0435","first-page":"3702","article-title":"Effect of elevated total cholesterol level and hypertension on the risk of fatal cardiovascular disease: a cohort study of Chinese steelworkers","volume":"124","author":"Yang","year":"2011","journal-title":"Chin Med J (Engl)"},{"issue":"8","key":"10.1016\/j.diabres.2023.111079_b0440","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1007\/s00125-014-3260-6","article-title":"Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events","volume":"57","author":"Peters","year":"2014","journal-title":"Diabetologia"},{"issue":"11","key":"10.1016\/j.diabres.2023.111079_b0445","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1136\/hrt.2008.147066","article-title":"Does cigarette smoking exacerbate the effect of total cholesterol and high-density lipoprotein cholesterol on the risk of cardiovascular diseases?","volume":"95","author":"Nakamura","year":"2009","journal-title":"Heart"},{"issue":"7","key":"10.1016\/j.diabres.2023.111079_b0450","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.005428","article-title":"Hyperkalemia after initiating renin-angiotensin system blockade: The Stockholm creatinine measurements (SCREAM) project","volume":"6","author":"Bandak","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"10.1016\/j.diabres.2023.111079_b0455","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s40262-015-0264-4","article-title":"Pharmacokinetics, pharmacodynamics and clinical Use of SGLT2 inhibitors in patients with type 2 diabetes mellitus and chronic kidney disease","volume":"54","author":"Scheen","year":"2015","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"10.1016\/j.diabres.2023.111079_b0460","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.atherosclerosis.2007.12.044","article-title":"Albuminuria and peripheral arterial disease: results from the multi-ethnic study of atherosclerosis (MESA)","volume":"201","author":"Wattanakit","year":"2008","journal-title":"Atherosclerosis"},{"issue":"8","key":"10.1016\/j.diabres.2023.111079_b0465","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007452","article-title":"Association of peripheral artery disease with incident atrial fibrillation: The ARIC (Atherosclerosis Risk in Communities) study","volume":"7","author":"Bekwelem","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"10.1016\/j.diabres.2023.111079_b0470","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: The framingham heart study","volume":"117","author":"D'Agostino","year":"2008","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.diabres.2023.111079_b0475","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1042\/cs1010671","article-title":"The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56)","volume":"101","author":"Stevens","year":"2001","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"10.1016\/j.diabres.2023.111079_b0480","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12933-018-0677-0","article-title":"Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The rio de janeiro type 2 diabetes cohort study","volume":"17","author":"Cardoso","year":"2018","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"10.1016\/j.diabres.2023.111079_b0485","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/pds.2345","article-title":"Macrovascular and microvascular outcomes after beginning of insulin versus additional oral glucose-lowering therapy in people with type 2 diabetes: An observational study","volume":"21","author":"Hall","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822723008422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822723008422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T17:04:03Z","timestamp":1740243843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822723008422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":97,"alternative-id":["S0168822723008422"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2023.111079","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors for peripheral artery disease and diabetic peripheral neuropathy among patients with type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2023.111079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111079"}}